1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Plasma extracellular matrix and inflammatory proteins as biomarkers for diagnosis, differentiation, and risk assessment in pulmonary arterial hypertension - utilizing Lund Cardio Pulmonary Registry
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2023
-
Mark
Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension
(
- Contribution to journal › Article
- 2022
-
Mark
Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension
(
- Contribution to journal › Article
- 2021
-
Mark
Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension
(
- Contribution to journal › Article
- 2020
-
Mark
Prolargin and matrix metalloproteinase-2 in heart failure after heart transplantation and their association with haemodynamics
(
- Contribution to journal › Article
-
Mark
Elevated plasma sRAGE and IGFBP7 in heart failure decrease after heart transplantation in association with haemodynamics
(
- Contribution to journal › Article
- 2019
-
Mark
Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension
(
- Contribution to journal › Article